11.58 USD
+0.04 (+0.35%)
11.58 USD
0 (0%)
Overall VREX gets a fundamental rating of 5 out of 10. We evaluated VREX against 188 industry peers in the Health Care Equipment & Supplies industry. VREX has an average financial health and profitability rating. VREX has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
VREX had positive earnings in the past year.
In the past year VREX had a positive cash flow from operations.
In multiple years VREX reported negative net income over the last 5 years.
Each year in the past 5 years VREX had a positive operating cash flow.
1.2 Ratios
VREX has a better Return On Assets (-6.35%) than 64.89% of its industry peers.
With a decent Return On Equity value of -14.88%, VREX is doing good in the industry, outperforming 63.30% of the companies in the same industry.
VREX has a better Return On Invested Capital (5.67%) than 78.72% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VREX is below the industry average of 8.78%.
The last Return On Invested Capital (5.67%) for VREX is above the 3 year average (4.82%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.35% | ||
| ROE | -14.88% | ||
| ROIC | 5.67% |
ROA(3y)-2.14%
ROA(5y)-0.47%
ROE(3y)-5.1%
ROE(5y)-1.2%
ROIC(3y)4.82%
ROIC(5y)5.54%
1.3 Margins
VREX has a better Operating Margin (7.83%) than 74.47% of its industry peers.
VREX's Operating Margin has declined in the last couple of years.
VREX has a Gross Margin of 34.40%. This is in the lower half of the industry: VREX underperforms 73.94% of its industry peers.
VREX's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.83% | ||
| PM (TTM) | N/A | ||
| GM | 34.4% |
OM growth 3Y-8.19%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5Y5.76%
2. Health
2.1 Basic Checks
VREX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, VREX has more shares outstanding
The number of shares outstanding for VREX has been increased compared to 5 years ago.
The debt/assets ratio for VREX has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.90 indicates that VREX is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.90, VREX is in line with its industry, outperforming 59.57% of the companies in the same industry.
VREX has a debt to FCF ratio of 19.87. This is a negative value and a sign of low solvency as VREX would need 19.87 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 19.87, VREX is doing good in the industry, outperforming 70.21% of the companies in the same industry.
VREX has a Debt/Equity ratio of 0.79. This is a neutral value indicating VREX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.79, VREX is doing worse than 70.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.79 | ||
| Debt/FCF | 19.87 | ||
| Altman-Z | 1.9 |
ROIC/WACC0.76
WACC7.5%
2.3 Liquidity
A Current Ratio of 3.43 indicates that VREX has no problem at all paying its short term obligations.
The Current ratio of VREX (3.43) is better than 62.77% of its industry peers.
A Quick Ratio of 1.83 indicates that VREX should not have too much problems paying its short term obligations.
VREX has a Quick ratio (1.83) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.43 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 60.00% over the past year.
Measured over the past years, VREX shows a very strong growth in Earnings Per Share. The EPS has been growing by 57.78% on average per year.
The Revenue has been growing slightly by 4.14% in the past year.
VREX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.73% yearly.
EPS 1Y (TTM)60%
EPS 3Y-14.54%
EPS 5Y57.78%
EPS Q2Q%94.74%
Revenue 1Y (TTM)4.14%
Revenue growth 3Y-0.58%
Revenue growth 5Y2.73%
Sales Q2Q%11.28%
3.2 Future
VREX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.20% yearly.
Based on estimates for the next years, VREX will show a small growth in Revenue. The Revenue will grow by 3.86% on average per year.
EPS Next Y-6.84%
EPS Next 2Y8.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.97%
Revenue Next 2Y3.86%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
VREX is valuated correctly with a Price/Earnings ratio of 13.16.
Compared to the rest of the industry, the Price/Earnings ratio of VREX indicates a rather cheap valuation: VREX is cheaper than 89.89% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.46, VREX is valued rather cheaply.
VREX is valuated correctly with a Price/Forward Earnings ratio of 14.12.
VREX's Price/Forward Earnings ratio is rather cheap when compared to the industry. VREX is cheaper than 88.83% of the companies in the same industry.
VREX is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.10, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.16 | ||
| Fwd PE | 14.12 |
4.2 Price Multiples
95.74% of the companies in the same industry are more expensive than VREX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, VREX is valued cheaply inside the industry as 82.98% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.69 | ||
| EV/EBITDA | 7.39 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.23
EPS Next 2Y8.2%
EPS Next 3YN/A
5. Dividend
5.1 Amount
VREX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
11.58
+0.04 (+0.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners96.22%
Inst Owner Change2.62%
Ins Owners1.65%
Ins Owner Change-1.28%
Market Cap482.89M
Revenue(TTM)844.60M
Net Income(TTM)-70.30M
Analysts83.64
Price Target17.54 (51.47%)
Short Float %2.04%
Short Ratio2.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)251.48%
Min EPS beat(2)98.76%
Max EPS beat(2)404.2%
EPS beat(4)4
Avg EPS beat(4)167.83%
Min EPS beat(4)81.21%
Max EPS beat(4)404.2%
EPS beat(8)5
Avg EPS beat(8)85.78%
EPS beat(12)9
Avg EPS beat(12)64.21%
EPS beat(16)12
Avg EPS beat(16)54.96%
Revenue beat(2)2
Avg Revenue beat(2)3.46%
Min Revenue beat(2)2.35%
Max Revenue beat(2)4.57%
Revenue beat(4)3
Avg Revenue beat(4)1.33%
Min Revenue beat(4)-3.1%
Max Revenue beat(4)4.57%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)5
Avg Revenue beat(12)-0.02%
Revenue beat(16)8
Avg Revenue beat(16)-0.05%
PT rev (1m)2.3%
PT rev (3m)2.3%
EPS NQ rev (1m)-2.44%
EPS NQ rev (3m)-8.05%
EPS NY rev (1m)0%
EPS NY rev (3m)1.42%
Revenue NQ rev (1m)0.72%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.16 | ||
| Fwd PE | 14.12 | ||
| P/S | 0.57 | ||
| P/FCF | 25.69 | ||
| P/OCF | 11.58 | ||
| P/B | 1.02 | ||
| P/tB | 1.86 | ||
| EV/EBITDA | 7.39 |
EPS(TTM)0.88
EY7.6%
EPS(NY)0.82
Fwd EY7.08%
FCF(TTM)0.45
FCFY3.89%
OCF(TTM)1
OCFY8.64%
SpS20.25
BVpS11.33
TBVpS6.24
PEG (NY)N/A
PEG (5Y)0.23
Graham Number14.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.35% | ||
| ROE | -14.88% | ||
| ROCE | 7.18% | ||
| ROIC | 5.67% | ||
| ROICexc | 6.83% | ||
| ROICexgc | 9.45% | ||
| OM | 7.83% | ||
| PM (TTM) | N/A | ||
| GM | 34.4% | ||
| FCFM | 2.23% |
ROA(3y)-2.14%
ROA(5y)-0.47%
ROE(3y)-5.1%
ROE(5y)-1.2%
ROIC(3y)4.82%
ROIC(5y)5.54%
ROICexc(3y)5.86%
ROICexc(5y)6.54%
ROICexgc(3y)8.71%
ROICexgc(5y)10.09%
ROCE(3y)6.1%
ROCE(5y)7.01%
ROICexgc growth 3Y-6.75%
ROICexgc growth 5YN/A
ROICexc growth 3Y-3.38%
ROICexc growth 5YN/A
OM growth 3Y-8.19%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5Y5.76%
F-Score5
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.79 | ||
| Debt/FCF | 19.87 | ||
| Debt/EBITDA | 3.98 | ||
| Cap/Depr | 84.19% | ||
| Cap/Sales | 2.71% | ||
| Interest Coverage | 2.11 | ||
| Cash Conversion | 44.69% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.43 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 1.9 |
F-Score5
WACC7.5%
ROIC/WACC0.76
Cap/Depr(3y)77.68%
Cap/Depr(5y)67.38%
Cap/Sales(3y)2.78%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60%
EPS 3Y-14.54%
EPS 5Y57.78%
EPS Q2Q%94.74%
EPS Next Y-6.84%
EPS Next 2Y8.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.14%
Revenue growth 3Y-0.58%
Revenue growth 5Y2.73%
Sales Q2Q%11.28%
Revenue Next Year2.97%
Revenue Next 2Y3.86%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y105.28%
EBIT growth 3Y-8.72%
EBIT growth 5YN/A
EBIT Next Year53.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.84%
OCF growth 3Y35.13%
OCF growth 5Y25.87%
VAREX IMAGING CORP / VREX FAQ
What is the fundamental rating for VREX stock?
ChartMill assigns a fundamental rating of 5 / 10 to VREX.
Can you provide the valuation status for VAREX IMAGING CORP?
ChartMill assigns a valuation rating of 6 / 10 to VAREX IMAGING CORP (VREX). This can be considered as Fairly Valued.
What is the profitability of VREX stock?
VAREX IMAGING CORP (VREX) has a profitability rating of 5 / 10.
Can you provide the financial health for VREX stock?
The financial health rating of VAREX IMAGING CORP (VREX) is 4 / 10.
What is the earnings growth outlook for VAREX IMAGING CORP?
The Earnings per Share (EPS) of VAREX IMAGING CORP (VREX) is expected to decline by -6.84% in the next year.